|
Re: Another variation
|
9
|
Resverlogix Corp.
|
Mar 04, 2021 07:48AM
|
|
Re: SF
|
9
|
Resverlogix Corp.
|
Sep 16, 2020 06:22PM
|
|
Re: My guess is a second BTD is coming
|
9
|
Resverlogix Corp.
|
Feb 08, 2020 02:24PM
|
|
Re: RVX Current Status
|
9
|
Resverlogix Corp.
|
Feb 27, 2020 09:54AM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
9
|
Resverlogix Corp.
|
Aug 17, 2022 12:27AM
|
|
Re: Sneaking Suspicion...
|
9
|
Resverlogix Corp.
|
Feb 04, 2021 08:48PM
|
|
Re: Tweet from Prof Kausik Ray
|
10
|
Resverlogix Corp.
|
Jun 02, 2020 11:36PM
|
|
Re: Link to 2023 AGM presentation is up
|
11
|
Resverlogix Corp.
|
Jun 27, 2023 01:27PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
11
|
Resverlogix Corp.
|
Jun 13, 2023 08:02AM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
11
|
Resverlogix Corp.
|
Mar 18, 2021 10:33AM
|
|
Re: approx. 85,000 deferred share units awarded
|
11
|
Resverlogix Corp.
|
Nov 05, 2020 03:44PM
|
|
Re: What are we waiting on?
|
11
|
Resverlogix Corp.
|
Dec 01, 2021 11:47AM
|
|
Re: Risk vs Reward moving forward!
|
12
|
Resverlogix Corp.
|
Dec 17, 2021 09:28PM
|
|
Re: BTD
|
13
|
Resverlogix Corp.
|
Apr 24, 2022 09:25AM
|
|
Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
13
|
Resverlogix Corp.
|
Nov 01, 2021 08:34AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
15
|
Resverlogix Corp.
|
Jun 13, 2020 10:50AM
|
|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
17
|
Resverlogix Corp.
|
Jan 18, 2020 03:35PM
|
|
Re: The move in the stock on Friday was disappointing.
|
21
|
Resverlogix Corp.
|
Nov 02, 2019 04:19PM
|
